AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ROCURONIUM BROMIDE
24 registrations across 4 African markets— 19 active
Markets with ROCURONIUM BROMIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| ESMERON 50MG/5ML SOLUTION FOR INJECTION (Each ml contains Rocuronium Bromide 10mg) | 🇬🇭Ghana | — | active | Feb 2031 |
| ESMERON 50MG/5ML SOLUTION FOR INJECTION (Each ml contains Rocuronium Bromide 10mg) | 🇬🇭Ghana | — | active | Feb 2031 |
| ROCURONIUM 50MG B. BRAUN SOLUTION; INJECTION | 🇿🇼Zimbabwe | B. BRAUN MEDICAL (PTY) LTD | active | Sept 2030 |
| MUSCOBLOC 50MG/5ML SOLUTION; INJECTION | 🇿🇼Zimbabwe | WMT PHARMACEUTICALS | active | Dec 2027 |
| CURON SOLUTION; INJECTION | 🇿🇼Zimbabwe | COSPHARM INVESTMENTS | active | Dec 2027 |
| RESTAN ROCURONIUM 100 mg | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | suspended | Aug 2025 |
| RESTAN-ROCURONIUM 50 mg | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | suspended | Aug 2025 |
| ESROC | 🇿🇦South Africa | Ranbaxy (SA) (Pty) Ltd | suspended | May 2025 |
| ROCURONIUM 100 mg/10 ml FRESENIUS | 🇿🇦South Africa | Fresenius Kabi South Africa (Pty) Ltd | suspended | Oct 2024 |
| ROCURONIUM 25 mg/2,5 ml FRESENIUS | 🇿🇦South Africa | Fresenius Kabi South Africa (Pty) Ltd | suspended | Dec 2023 |
| ROCURONIUM 50 mg/5 ml FRESENIUS | 🇿🇦South Africa | Fresenius Kabi South Africa (Pty) Ltd | active | Oct 2023 |
| ESMERON 100 mg | 🇿🇦South Africa | MSD (Pty) Ltd | active | Jan 1900 |
| SANDOZ ROCURONIUM 50 | 🇿🇦South Africa | Dezzo Trading 392 (Pty) Ltd | active | Jan 1900 |
| MERAXT 10 mg/ml | 🇿🇦South Africa | KAHMA BIOTECH (Pty) Ltd | active | Jan 1900 |
| IMMAROC | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 1900 |
| ROCURONIUM 50 IV BIOTECH | 🇿🇦South Africa | Biotech Laboratories (Pty) Ltd | active | Jan 1900 |
| EURONOM | 🇿🇦South Africa | Activo Health (Pty) Ltd | active | Jan 1900 |
| ADCO ROCURONIUM 100 mg | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | active | Jan 1900 |
| COVAN ROCURONIUM 50 mg | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | active | Jan 1900 |
| ESMERON 50 mg | 🇿🇦South Africa | MSD (Pty) Ltd | active | Jan 1900 |
| COVAN ROCURONIUM 100 mg | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | active | Jan 1900 |
| SANDOZ ROCURONIUM 100 | 🇿🇦South Africa | Dezzo Trading 392 (Pty) Ltd | active | Jan 1900 |
| ADCO ROCURONIUM 50 mg | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | active | Jan 1900 |
| Brimo Ophthalmic Solution | 🇹🇿Tanzania | JAMJOOM PHARMACEUTICALS COMPANY | active | — |
ROCURONIUM BROMIDE in Africa — Regulatory Overview
ROCURONIUM BROMIDE is registered across 4 African markets with 24 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Zimbabwe, Ghana, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.
Of the 24 registrations, 19 (79%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.